Is pricing of dolutegravir equitable? A comparative analysis of price and country income level in 52 countries

OBJECTIVES: Differences in marketed prices of antiretrovirals raises questions about the fairness of pricing medicines of significant public health importance such as dolutegravir (DTG). In view of the reduced prices of generically available efavirenz (EFV), there is a need to determine if previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Joel, Hill, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248837/
https://www.ncbi.nlm.nih.gov/pubmed/30515303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248837/
https://www.ncbi.nlm.nih.gov/pubmed/30515303

Ejemplares similares